Long- Versus Short-Acting β2-Agonists: Implications for Drug Therapy

LP Boulet - Drugs, 1994 - Springer
Evaluation of the role of adrenergic agents as bronchodilators started at the beginning of the
century. In 1900, Solis-Cohen discovered a bronchodilator substance derived from the …
被引用次数：82 相关文章

[引用][C] Long-versus short-acting β_2agonists. Implications for drug therapy

LP BOULET - Drugs, 1994 - cir.nii.ac.jp
Long-versus short-acting β_2agonists. Implications for drug therapy | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

[引用][C] Long-versus short-acting beta 2-agonists. Implications for drug therapy.

LP Boulet - Drugs, 1994 - europepmc.org
Long- versus short-acting beta 2-agonists. Implications for drug therapy. - Abstract - Europe
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers …

[引用][C] Long-versus short-acting β2-agonists: implications for drug therapy

LP BOULET - Drugs (Basel), 1994 - pascal-francis.inist.fr
Long-versus short-acting β2-agonists : implications for drug therapy CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search …

[引用][C] Long-versus short-acting beta 2-agonists. Implications for drug therapy

LP Boulet - Drugs, 1994 - pubmed.ncbi.nlm.nih.gov

[引用][C] Long-versus short-acting β2-agonists: implications for drug therapy

LP BOULET - Drugs, 1994 - Adis International